Birth Cohort in Rahimyar Khan, Pakistan
Launched by THE HOSPITAL FOR SICK CHILDREN · Sep 5, 2014
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
In 2010, 7.6 million children under the age of five died worldwide (Liu et al., 2012). Notably, the burden of under-five mortality varies dramatically by country. The majority of total child deaths in 2010 were seen in Africa (3.6 million) and southeast Asia (2.1 million deaths), compared to 0.16 million and 0.28 million under-five deaths in Europe and the Americas, respectively (Liu et al., 2012). Strikingly, nearly half of the world's under-five child deaths in 2010 could be attributed to only five countries: India, Nigeria, Democratic Republic of the Congo, Pakistan, and China (Liu et al...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All pregnant women and their home- or facility-born live newborns that consented to participate in the control arm of the intervention trial "An integrated toolkit to save newborn lives in Pakistan" (NCT02130856) will be eligible for this study
- Exclusion Criteria:
- • Did not consent to participate in the control arm of "An integrated toolkit to save newborn lives in Pakistan"(NCT02130856). Since the birth cohort study has been designed to utilize a portion of the data collected in the neonatal kit trial, individuals who do not enroll in the kit study will not be eligible to participate in birth cohort study as they will not have a complete set of data.
- • Failure to provide consent to enroll in this study.
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, , Pakistan
Patients applied
Trial Officials
Shaun K Morris, MD, MPH
Principal Investigator
The Hospital for Sick Children
Zulfiqar A. Bhutta, PhD, MBBS
Principal Investigator
Aga Khan University and The Hospital for Sick Children
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials